Latest filing published 01 Apr 2022 for Aarti Drugs Limited, €857k.
Renil Rajendra Gogri is a declared insider of Aarti Drugs Limited (chief executive), with filings sourced from SEBI (PIT + SAST). Over a trading history stretching from 18 May 2021 to 31 March 2022, the count stands at 3 filings.
The open-market record consists of 2 sales worth €1.8M, with no purchase. Since January 2022: no purchases and 2 sales on the market.
Most recently, on 1 April 2022, the filings show an open-market sale worth €857k in Aarti Drugs Limited. Typically, a trade is published a median of 2 days after it takes place. This delay matters because a trade only becomes useful information once it is public. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEBI (PIT + SAST) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations